offline
Novartis stock falls after FDA says Zolgensma's BLA had a "data manipulation issue"
Shares of Novartis AG NVS, -2.92% tumbled 3% Tuesday afternoon after the U.S. Food and Drug Administration said the company's AveXis unit had informed the agency of a data manipulation issue in the marketing application of pricey gene-therapy Zolgensma.
...
https://www.marketwatch.com/story/novart...latestnews
Shares of Novartis AG NVS, -2.92% tumbled 3% Tuesday afternoon after the U.S. Food and Drug Administration said the company's AveXis unit had informed the agency of a data manipulation issue in the marketing application of pricey gene-therapy Zolgensma.
...
https://www.marketwatch.com/story/novart...latestnews
__________________
